Replies to post #4898 on Arch Therapeutics Inc (ARTH)

[21money21]

Good article 512, thanks for sharing.

[Amatuer17]

Good report but one key -it says AC5 is in preclinical phase

"As recently, Arch Therapeutics, Inc. has developed a revolutionary product to stop bleeding faster than any other product available in market by the name AC5.
AC5 is currently in preclinical testing and takes an average time of 15 seconds to stop bleeding in comparison to 80 seconds to 300 seconds taken by other treatments methods."